Longer-term Outcomes of Darbepoetin Alfa Versus Epoetin Alfa in Patients With ESRD Initiating Hemodialysis: A Quasi-experimental Cohort Study
Conclusions In incident hemodialysis patients, mortality and cardiovascular event rates did not differ between patients treated at facilities predominantly using DPO versus EPO.
Source: American Journal of Kidney Diseases - Category: Urology & Nephrology Source Type: research
More News: Aranesp | Cardiology | Cardiovascular | Dialysis | Epogen | Heart | Heart Attack | Hemodialysis | Medicare | Procrit | Stroke | Study | Urology & Nephrology